Literature DB >> 28251864

Typologies of Altruistic and Financial Motivations for Research Participation.

Lisa J Chin1, Jacqueline A Berenson2, Robert L Klitzman3.   

Abstract

Questions arise concerning participants' motives in risky studies, such as HIV vaccine trials (HVTs). We interviewed in-depth 20 gay/bisexual men. Participants described both altruistic and nonaltruistic motives. Altruistic motivations emerged primarily, with nine typologies: (a) cultural, (b) community related, (c) familial, (d) religious, (e) professional, (f) political (e.g., HIV activism), (g) moral (e.g., making up for past wrongs), (h) existential (e.g., providing sense of meaning), and (i) other psychological (e.g., emotional gratification). Views of compensation varied: not a factor (55%), added incentive (25%), main motivator, but in conjunction with altruism (15%), and primary motivator (5%). HVT participants thus often have both altruistic and financial motives, and related typologies emerged. These findings have critical implications for studies on HIV, other conditions, and research ethics.

Entities:  

Keywords:  HIV vaccine trial; altruism; benefits; compensation; motivators for participation; risks

Mesh:

Substances:

Year:  2016        PMID: 28251864      PMCID: PMC5334779          DOI: 10.1177/1556264616679537

Source DB:  PubMed          Journal:  J Empir Res Hum Res Ethics        ISSN: 1556-2646            Impact factor:   1.742


  39 in total

1.  Recruitment and retention of minority women in cancer screening, prevention, and treatment trials.

Authors:  D R Brown; M N Fouad; K Basen-Engquist; G Tortolero-Luna
Journal:  Ann Epidemiol       Date:  2000-11       Impact factor: 3.797

2.  Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania.

Authors:  Edith A M Tarimo; Anna Thorson; Thecla W Kohi; Joachim Mwami; Muhammad Bakari; Eric Sandström; Asli Kulane
Journal:  BMC Public Health       Date:  2010-05-28       Impact factor: 3.295

3.  Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda.

Authors:  Eugene Ruzagira; Symon Wandiembe; Leonard Bufumbo; Jonathan Levin; Matthew A Price; Heiner Grosskurth; Anatoli Kamali
Journal:  Trop Med Int Health       Date:  2009-01-15       Impact factor: 2.622

4.  Participation in two phase II prophylactic HIV vaccine trials in the UK.

Authors:  Kimberly Gray; K Legg; A Sharp; N Mackie; F Olarinde; C De Souza; J Weber; B Peters
Journal:  Vaccine       Date:  2008-04-09       Impact factor: 3.641

5.  What attitudes and beliefs underlie patients' decisions about participating in chemotherapy trials?

Authors:  H J Sutherland; R da Cunha; G A Lockwood; J E Till
Journal:  Med Decis Making       Date:  1998 Jan-Mar       Impact factor: 2.583

6.  An investigation of patients' motivations for their participation in genetics-related research.

Authors:  N Hallowell; S Cooke; G Crawford; A Lucassen; M Parker; C Snowdon
Journal:  J Med Ethics       Date:  2010-01       Impact factor: 2.903

7.  Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE.

Authors:  B A Koblin; S Avrett; P E Taylor; C E Stevens
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-06-01

8.  Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities.

Authors:  R P Strauss; S Sengupta; S Kegeles; E McLellan; D Metzger; S Eyre; F Khanani; C B Emrick; K M MacQueen
Journal:  J Acquir Immune Defic Syndr       Date:  2001-01-01       Impact factor: 3.731

9.  Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial.

Authors:  Clayton D Harro; Franklyn N Judson; Geoffrey J Gorse; Kenneth H Mayer; Jay R Kostman; Stephen J Brown; Beryl Koblin; Michael Marmor; Bradford N Bartholow; Vladimir Popovic
Journal:  J Acquir Immune Defic Syndr       Date:  2004-11-01       Impact factor: 3.731

10.  Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research.

Authors:  Laura B Dunn; Daniel S Kim; Ian E Fellows; Barton W Palmer
Journal:  Schizophr Bull       Date:  2008-02-14       Impact factor: 9.306

View more
  11 in total

1.  Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366.

Authors:  Karine Dubé; Lara Hosey; Kate Starr; Liz Barr; David Evans; Erin Hoffman; Danielle M Campbell; Jane Simoni; Jeremy Sugarman; John Sauceda; Brandon Brown; Karen L Diepstra; Catherine Godfrey; Daniel R Kuritzkes; David A Wohl; Rajesh Gandhi; Eileen Scully
Journal:  AIDS Res Hum Retroviruses       Date:  2020-04       Impact factor: 2.205

2.  A Relational Framework for Engaging Latino Sexual Minority Men in Sexual and Behavioral Health Research.

Authors:  Audrey Harkness; Brooke G Rogers; Daniel Mayo; Rosana Smith-Alvarez; John E Pachankis; Steven A Safren
Journal:  Arch Sex Behav       Date:  2022-06-28

3.  Perceptions of Risks and Benefits of Participating in HIV Cure-Related Research Among Diverse Young Adults Living with HIV in the United States: Qualitative Research Findings.

Authors:  Parya Saberi; Chadwick K Campbell; John A Sauceda; Samuel Ndukwe; Karine Dubé
Journal:  AIDS Res Hum Retroviruses       Date:  2022-06-28       Impact factor: 1.723

4.  Research altruism as motivation for participation in community-centered environmental health research.

Authors:  Jennifer S Carrera; Phil Brown; Julia Green Brody; Rachel Morello-Frosch
Journal:  Soc Sci Med       Date:  2017-11-21       Impact factor: 4.634

5.  "My Death Will Not [Be] in Vain": Testimonials from Last Gift Rapid Research Autopsy Study Participants Living with HIV at the End of Life.

Authors:  Kelly E Perry; Karine Dubé; Susanna Concha-Garcia; Hursch Patel; Andy Kaytes; Jeff Taylor; Sogol Stephanie Javadi; Kushagra Mathur; Megan Lo; Brandon Brown; John A Sauceda; David A Wohl; Susan Little; Steven Hendrickx; Stephen A Rawlings; Davey M Smith; Sara Gianella
Journal:  AIDS Res Hum Retroviruses       Date:  2020-06-24       Impact factor: 2.205

6.  Acceptability of a long-acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076).

Authors:  Elizabeth E Tolley; Sue Li; Sahar Z Zangeneh; Millicent Atujuna; Petina Musara; Jessica Justman; Subash Pathak; Linda-Gail Bekker; Shobha Swaminathan; Jill Stanton; Jennifer Farrior; Nirupama Sista
Journal:  J Int AIDS Soc       Date:  2019-10       Impact factor: 5.396

Review 7.  Altruism: Scoping review of the literature and future directions for HIV cure-related research.

Authors:  Karine Dubé; Kelly E Perry; Kushagra Mathur; Megan Lo; Sogol S Javadi; Hursch Patel; Susanna Concha-Garcia; Jeff Taylor; Andy Kaytes; Lynda Dee; Danielle Campbell; John Kanazawa; David Smith; Sara Gianella; Judith D Auerbach; Parya Saberi; John A Sauceda
Journal:  J Virus Erad       Date:  2020-08-25

8.  Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis.

Authors:  Catherine Houghton; Maura Dowling; Pauline Meskell; Andrew Hunter; Heidi Gardner; Aislinn Conway; Shaun Treweek; Katy Sutcliffe; Jane Noyes; Declan Devane; Jane R Nicholas; Linda M Biesty
Journal:  Cochrane Database Syst Rev       Date:  2020-10-07

9.  "Free Testing and PrEP without Outing Myself to Parents:" Motivation to participate in oral and injectable PrEP clinical trials among adolescent men who have sex with men.

Authors:  Celia B Fisher; Adam L Fried; Leah Ibrahim Puri; Kathryn Macapagal; Brian Mustanski
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

10.  Factors associated with attitudes towards HIV cure research among transgender women and travestis: a cross-sectional survey in São Paulo, Brazil.

Authors:  Robert J Wozniak; Natalia B Cerqueira; Maria Candida S Dantas; Bianca Mahafe; Daniel A C Barros; Edmilson Alves de Medeiros; Ana Carolina Soares de Oliveira; Thiago Sabino; Albert Roggenbuck; Vivian Iida Avelino-Silva; Carrie D Johnston; Jez L Marston; Sebastian C Bidegain; Manya Magnus; Esper G Kallas; Douglas F Nixon; Camila S Donini
Journal:  BMJ Open       Date:  2020-11-11       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.